Randy Milby Hillstream Bio Pharma Inc. (HILS) insider trading activity

HILS Quotes by TradingView

Randy Milby is CEO of Hillstream BioPharma Inc.. Currently has a direct ownership of 17,534 shares of HILS, which is worth approximately $50,497. The most recent transaction as insider was on Dec 19, 2024, when has been sold 4,600 shares (Common Stock) at a price of $2.12 per share, resulting in proceeds of $9,752. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.5K
88.8% 3M change
88.8% 12M change
Total Value Held $50,497

RANDY MILBY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2024
BUY
Open market or private purchase
$9,752 $2.12 p/Share
4,600 Added 20.78%
17,534 Common Stock
Oct 08 2024
BUY
Open market or private purchase
$5,225 $2.09 p/Share
2,500 Added 16.2%
12,934 Common Stock
Dec 15 2023
BUY
Open market or private purchase
$14,500 $0.5 p/Share
29,000 Added 15.63%
156,517 Common Stock
Nov 30 2023
BUY
Open market or private purchase
$10,000 $1.0 p/Share
10,000 Added 7.27%
127,517 Common Stock
Jun 17 2022
BUY
Open market or private purchase
$390 $0.78 p/Share
500 Added 0.02%
2,937,940 Common Stock
Jun 06 2022
BUY
Open market or private purchase
$680 $0.68 p/Share
1,000 Added 0.03%
2,938,540 Common Stock
Jun 01 2022
BUY
Open market or private purchase
$1 $0.94 p/Share
1 Added 0.0%
2,937,540 Common Stock
May 25 2022
BUY
Open market or private purchase
$780 $0.78 p/Share
1,000 Added 0.03%
2,937,539 Common Stock
May 20 2022
BUY
Open market or private purchase
$920 $0.92 p/Share
1,000 Added 0.03%
2,936,539 Common Stock
May 19 2022
BUY
Open market or private purchase
$910 $0.91 p/Share
1,000 Added 0.03%
2,935,539 Common Stock
Apr 18 2022
BUY
Exercise of in-the-money or at-the-money derivatives securities
$52,916 $0.22 p/Share
240,526 Added 7.58%
2,934,539 Common Stock
Jan 14 2022
BUY
Conversion of derivative security
$1,229,840 $3.2 p/Share
384,325 Added 15.12%
2,157,050 Common Stock
Jan 14 2022
BUY
Conversion of derivative security
$834,157 $3.2 p/Share
260,674 Added 9.73%
2,417,724 Common Stock
Jan 14 2022
BUY
Conversion of derivative security
$884,125 $3.2 p/Share
276,289 Added 9.3%
2,694,013 Common Stock
RM

Randy Milby

CEO
Bridgewater, NJ

Track Institutional and Insider Activities on HILS

Follow Hillstream BioPharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HILS shares.

Notify only if

Insider Trading

Get notified when an Hillstream Bio Pharma Inc. insider buys or sells HILS shares.

Notify only if

News

Receive news related to Hillstream BioPharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HILS